Skip to content
10-K

Annual Report

Verona Pharma plc

0001657312-25-000010

← back to feed
Filed
Feb 27, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Feb 24, 2025 679.83M sh
Shares Diluted FY 2024 · Dec 31, 2024 652.31M sh
Shares Diluted FY 2024 · Dec 31, 2023 634.14M sh
Shares Diluted FY 2024 · Dec 31, 2022 529.07M sh
Capex FY 2024 · Dec 31, 2024 $580K
Capex FY 2024 · Dec 31, 2023 $0
Capex FY 2024 · Dec 31, 2022 $29K
Operating Cash Flow FY 2024 · Dec 31, 2024 −$122.2M
Operating Cash Flow FY 2024 · Dec 31, 2023 −$50.22M
Operating Cash Flow FY 2024 · Dec 31, 2022 −$59.86M
Long Term Debt FY 2024 · Dec 31, 2024 $120.34M
Long Term Debt FY 2024 · Dec 31, 2023 $48.37M
Cash And Equivalents FY 2024 · Dec 31, 2024 $399.76M
Cash And Equivalents FY 2024 · Dec 31, 2023 $271.77M
Stockholders Equity FY 2024 · Dec 31, 2024 $204.56M
Stockholders Equity FY 2024 · Dec 31, 2023 $249.28M
Stockholders Equity FY 2024 · Dec 31, 2022 $230.47M
Stockholders Equity FY 2024 · Dec 31, 2021 $148.01M
Current Liabilities FY 2024 · Dec 31, 2024 $42.68M
Current Liabilities FY 2024 · Dec 31, 2023 $8.69M
Total Liabilities FY 2024 · Dec 31, 2024 $269.68M
Total Liabilities FY 2024 · Dec 31, 2023 $58.84M
Current Assets FY 2024 · Dec 31, 2024 $453.57M
Current Assets FY 2024 · Dec 31, 2023 $289.71M
Total Assets FY 2024 · Dec 31, 2024 $474.24M
Total Assets FY 2024 · Dec 31, 2023 $308.12M
Eps Diluted FY 2024 · Dec 31, 2024 −$0.27
Eps Diluted FY 2024 · Dec 31, 2023 −$0.09
Eps Diluted FY 2024 · Dec 31, 2022 −$0.13
Eps Basic FY 2024 · Dec 31, 2024 −$0.27
Eps Basic FY 2024 · Dec 31, 2023 −$0.09
Eps Basic FY 2024 · Dec 31, 2022 −$0.13
Sga Expense FY 2024 · Dec 31, 2024 $149.75M
Sga Expense FY 2024 · Dec 31, 2023 $50.35M
Sga Expense FY 2024 · Dec 31, 2022 $26.58M
Rd Expense FY 2024 · Dec 31, 2024 $44.57M
Rd Expense FY 2024 · Dec 31, 2023 $17.22M
Rd Expense FY 2024 · Dec 31, 2022 $49.28M
Net Income FY 2024 · Dec 31, 2024 −$173.42M
Net Income FY 2024 · Dec 31, 2023 −$54.37M
Net Income FY 2024 · Dec 31, 2022 −$68.7M
Operating Income FY 2024 · Dec 31, 2024 −$154.63M
Operating Income FY 2024 · Dec 31, 2023 −$67.57M
Operating Income FY 2024 · Dec 31, 2022 −$75.75M
Revenue FY 2024 · Dec 31, 2024 $42.28M
Revenue FY 2024 · Dec 31, 2023 $0
Revenue FY 2024 · Dec 31, 2022 $458K